ID: ALA2313627

Max Phase: Preclinical

Molecular Formula: C28H32N6O8S

Molecular Weight: 612.66

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](n3cc(-c4ccccc4)nn3)[C@H]2O)[C@H](O)[C@@H](n2cc(-c3ccccc3)nn2)[C@H]1O

Standard InChI:  InChI=1S/C28H32N6O8S/c35-13-19-23(37)21(33-11-17(29-31-33)15-7-3-1-4-8-15)25(39)27(41-19)43-28-26(40)22(24(38)20(14-36)42-28)34-12-18(30-32-34)16-9-5-2-6-10-16/h1-12,19-28,35-40H,13-14H2/t19-,20-,21+,22+,23+,24+,25-,26-,27+,28+/m1/s1

Standard InChI Key:  KPVDZDWKPRUGKK-MQFIMZJJSA-N

Associated Targets(Human)

Galectin-3 545 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Galectin-1 387 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 612.66Molecular Weight (Monoisotopic): 612.2002AlogP: -0.40#Rotatable Bonds: 8
Polar Surface Area: 201.26Molecular Species: NEUTRALHBA: 15HBD: 6
#RO5 Violations: 3HBA (Lipinski): 14HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.52CX Basic pKa: 0.06CX LogP: 0.76CX LogD: 0.76
Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.15Np Likeness Score: -0.09

References

1. van Hattum H, Branderhorst HM, Moret EE, Nilsson UJ, Leffler H, Pieters RJ..  (2013)  Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1.,  56  (3): [PMID:23281927] [10.1021/jm301677r]

Source